Investigational Drug Information for GDC-0084
✉ Email this page to a colleague
What is the drug development status for GDC-0084?
GDC-0084 is an investigational drug.
There have been 9 clinical trials for GDC-0084.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 30th 2019.
The most common disease conditions in clinical trials are Glioma, Glioblastoma, and Brain Neoplasms. The leading clinical trial sponsors are Kazia Therapeutics Limited, Genentech, Inc., and Kazia Therapeutics.
Summary for GDC-0084
| US Patents | 0 |
| International Patents | 44 |
| US Patent Applications | 21 |
| WIPO Patent Applications | 16 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 1 (2019-07-30) |
| Vendors | 44 |
Recent Clinical Trials for GDC-0084
| Title | Sponsor | Phase |
|---|---|---|
| Combination Therapy for the Treatment of Diffuse Midline Gliomas | Mithil Prasad Foundation | Phase 2 |
| Combination Therapy for the Treatment of Diffuse Midline Gliomas | Storm the Heavens Fund | Phase 2 |
| Combination Therapy for the Treatment of Diffuse Midline Gliomas | The Chad-Tough Defeat DIPG Foundation | Phase 2 |
Clinical Trial Summary for GDC-0084
Top disease conditions for GDC-0084
Top clinical trial sponsors for GDC-0084
US Patents for GDC-0084
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
